Case report: Successful treatment of refractory membranous nephropathy with telitacicept

Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Jin, Hua, Wang, Dong, Wang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616774/
https://www.ncbi.nlm.nih.gov/pubmed/37915584
http://dx.doi.org/10.3389/fimmu.2023.1268929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616774/
https://www.ncbi.nlm.nih.gov/pubmed/37915584
http://dx.doi.org/10.3389/fimmu.2023.1268929

Ejemplares similares